NDAORALTABLET
Approved
Nov 2001
Lifecycle
LOE Approaching
Competitive Pressure
30/100
Data completeness
1/8 — Limited
Drug data last refreshed 3h ago · AI intelligence enriched 6d ago
AI summarySynthesized from FDA + DailyMed + ClinicalTrials.gov data
TEVETEN HCT is a fixed-dose combination tablet containing eprosartan mesylate (an angiotensin II receptor blocker) and hydrochlorothiazide (a thiazide diuretic) for oral administration. It is indicated for the treatment of hypertension in patients requiring dual antihypertensive therapy. The combination works by blocking angiotensin II receptors to reduce vasoconstriction while the diuretic reduces blood volume.
LOE Approaching
Product is approaching loss of exclusivity with moderate competitive pressure (30/100), suggesting defensive rather than growth-focused team positioning.
Mechanism of Action
Mechanism of action data is being enriched from DailyMed and FDA sources. Check back soon for updated drug intelligence.
Indications
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
Career Relevance
Working on TEVETEN HCT offers limited growth opportunities but provides valuable experience in defensive brand management, generic transition planning, and mature product lifecycle strategies. This role is suited for professionals interested in market access, cost management, and portfolio optimization rather than launch-focused innovation.
Brand ManagerField Sales Representative
Worked on TEVETEN HCT at AbbVie? Share your interview experience or compensation data (+7 days Pro)
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.